Bleakley Financial Group LLC Acquires 30,702 Shares of Kenvue Inc. $KVUE

Bleakley Financial Group LLC lifted its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 11.0% in the 1st quarter, Holdings Channel reports. The institutional investor owned 309,109 shares of the company’s stock after acquiring an additional 30,702 shares during the period. Bleakley Financial Group LLC’s holdings in Kenvue were worth $5,329,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of KVUE. Physician Wealth Advisors Inc. boosted its position in shares of Kenvue by 67.5% in the 4th quarter. Physician Wealth Advisors Inc. now owns 1,533 shares of the company’s stock worth $26,000 after purchasing an additional 618 shares during the last quarter. Elyxium Wealth LLC acquired a new position in Kenvue in the fourth quarter valued at about $26,000. MV Capital Management Inc. acquired a new position in Kenvue in the fourth quarter valued at about $28,000. Reflection Asset Management bought a new position in Kenvue during the fourth quarter worth about $32,000. Finally, SBI Securities Co. Ltd. boosted its holdings in Kenvue by 82.4% during the fourth quarter. SBI Securities Co. Ltd. now owns 2,273 shares of the company’s stock worth $39,000 after buying an additional 1,027 shares during the last quarter. 97.64% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other Kenvue news, General Counsel Matthew Orlando sold 38,491 shares of the firm’s stock in a transaction on Friday, May 8th. The stock was sold at an average price of $17.66, for a total transaction of $679,751.06. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Company insiders own 1.59% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently commented on KVUE shares. UBS Group lowered their price target on Kenvue from $19.00 to $18.00 and set a “neutral” rating for the company in a research note on Tuesday, April 7th. Wall Street Zen upgraded Kenvue to a “buy” rating in a report on Sunday. Citigroup decreased their price objective on Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a report on Wednesday, April 15th. Weiss Ratings raised shares of Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a research note on Monday, June 15th. Finally, Zacks Research downgraded shares of Kenvue from a “strong-buy” rating to a “hold” rating in a report on Tuesday, July 7th. Three research analysts have rated the stock with a Buy rating and thirteen have given a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $19.33.

Kenvue Trading Down 2.4%

Kenvue stock opened at $18.76 on Wednesday. The stock has a 50-day simple moving average of $18.12 and a 200 day simple moving average of $17.82. The stock has a market capitalization of $36.02 billion, a P/E ratio of 22.07, a PEG ratio of 1.46 and a beta of 0.47. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.70 and a current ratio of 0.98. Kenvue Inc. has a 52 week low of $14.02 and a 52 week high of $22.87.

Kenvue (NYSE:KVUE) last released its quarterly earnings data on Thursday, May 7th. The company reported $0.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.27 by $0.05. Kenvue had a return on equity of 20.81% and a net margin of 10.61%.The firm had revenue of $3.91 billion for the quarter, compared to analyst estimates of $3.84 billion. During the same quarter in the prior year, the company earned $0.24 earnings per share. The business’s revenue for the quarter was up 4.5% compared to the same quarter last year. Analysts expect that Kenvue Inc. will post 1.16 earnings per share for the current year.

Kenvue Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 27th. Investors of record on Wednesday, May 13th were paid a $0.2075 dividend. This represents a $0.83 dividend on an annualized basis and a yield of 4.4%. The ex-dividend date was Wednesday, May 13th. Kenvue’s dividend payout ratio is 97.65%.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.